Where can prostate cancer metastasize to?

Written by Zhou Zi Hua
Oncology
Updated on September 20, 2024
00:00
00:00

When prostate cancer invades surrounding tissues and structures, it can cause a variety of clinical symptoms, including urinary irritation, urinary obstruction, urinary incontinence, sciatica, erectile dysfunction, etc., and can compress causing unilateral or bilateral hydronephrosis. In severe cases, when the tumor invades the rectum, it can cause difficulty in defecation or colon obstruction. When the cancer metastasizes to the bones, it can cause bone pain and pathological fractures, and may also spread to the lungs.

Other Voices

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
27sec home-news-image

Late-stage prostate cancer with bone metastases: how long can one survive?

Bone metastasis is the most common site of metastasis for prostate cancer. If prostate cancer has metastasized to the bones, it means it is not in its early stages but has entered the advanced stages. However, this type of tumor is not like others with a higher degree of malignancy. If it has a good sensitivity to hormone therapy, after our standardized treatment, the survival time can still be quite long.

doctor image
home-news-image
Written by Cui Fang Bo
Oncology
38sec home-news-image

Prostate cancer IV is stage 4.

Prostate cancer stage IV refers to stage four prostate cancer, which is a common type of male reproductive organ tumor, particularly prevalent among elderly men. Stage four prostate cancer means that the tumor is not confined to the prostate and has already shown corresponding distant metastasis. The most common sites of metastasis for prostate cancer are the bones, followed by the lungs, liver, and others. When metastasis of prostate cancer occurs, it is considered to be at a late stage, and the primary treatments include endocrine therapy, chemotherapy, etc., with a poor prognosis.

doctor image
home-news-image
Written by Liu Liang
Oncology
56sec home-news-image

What indicators are checked for prostate cancer?

Prostate-Specific Antigen (PSA) is a glycoprotein produced by the vesicles in the cytoplasm of normal or pre-cancerous epithelial cells of the prostate. It is the most specific and sensitive tumor marker for prostate cancer. Therefore, in patients with prostate cancer, we generally conduct blood tests for PSA, especially in screening for prostate cancer, assessing the effectiveness of treatments, and for the prognosis of prostate patients, among other aspects. Additionally, other examinations are combined, such as digital rectal exams, which can also serve as a screening method for prostate cancer. Moreover, CT or MRI scans of the prostate and pelvis, as well as ultrasound examinations of the prostate, can be used in conjunction with the tumor marker PSA for a comprehensive evaluation.

doctor image
home-news-image
Written by Yan Chun
Oncology
56sec home-news-image

Is vomiting in prostate cancer due to metastasis to the liver?

Patients with prostate cancer may experience vomiting due to the metastasis of the disease to the liver, causing damage to liver function. However, vomiting could also be caused by other reasons, such as the metastasis of prostate cancer to the peritoneum of the abdominal cavity. Clinically, this can lead to cancerous intestinal obstruction, with symptoms commonly including vomiting, abdominal pain, bloating, reduced bowel movements and gas, or cessation of bowel movements and gas. When prostate cancer metastasizes to the brain, the increased intracranial pressure can also cause symptoms such as vomiting, headache, swelling of the optic disc, hemiplegia, and aphasia. Additionally, some prostate cancer patients may experience vomiting due to toxic side effects from treatments such as chemotherapy and targeted therapy.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
31sec home-news-image

What are the symptoms of bone metastasis from prostate cancer?

Bone metastasis is the most common site of metastasis for prostate cancer, with the lumbar vertebrae being the most common site. Eighty percent of bone metastases in prostate cancer are osteoblastic changes. The main symptoms caused by bone metastasis are bone pain, pathological fractures, anemia, and if the spinal cord is compressed, it can cause paralysis of the lower limbs, weakness, incontinence, and other symptoms.